Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

Cochrane database of systematic reviews (Online)

Volumn , Issue 4, 2000, Pages

  van Der Heijden JF, ^a   Hutten, B A ^a   Buller H R ^a   Prins, M H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN K GROUP;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK; VEIN THROMBOSIS;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; VENOUS THROMBOSIS; VITAMIN K;

EID: 0034564632     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (24)